Cancer Care Ontario | Cancer Care Ontario

You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

126 Results

Guidelines and Advice

An Endorsement of the ASCO-SNO Guideline on Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults

Status: Current
ID: GL END 9-10
Version: 2

Aug 2022

Guidelines and Advice

Lung Cancer Imaging Guidelines: Integration with the Lung Cancer Diagnosis and Staging Clinical Pathway - Full Document

Status: Current
ID: GL-C50-11

Jan 2014

Guidelines and Advice

Evidence from Primary Studies and Systematic Reviews and Recommendations from Clinical Practice Guidelines January to June 2021

Status: Current
ID: PET 2021-1

Jan 2022

Guidelines and Advice

Evidence from Primary Studies and Systematic Reviews and Recommendations from Clinical Practice Guidelines July to December 2021

Status: Current
ID: PET 2021-2

Jun 2022

Guidelines and Advice

PET Evidence from Primary Studies and Systematic Reviews and Recommendations from Clinical Practice Guidelines January to June 2014

Status: Current
ID: PET 2014-1

Dec 2014

Guidelines and Advice

PET Evidence from Primary Studies and Systematic Reviews and Recommendations from Clinical Practice Guidelines July to Dec 2013

Status: Current
ID: PET 2013-2

Sep 2014

Guidelines and Advice

The Use of Indoor Tanning Devices and the Risk of Developing Cutaneous Malignant Melanoma: A Systematic Review and Clinical Practice Guideline

Status: In-Review
ID: 8-8

Aug 2014

Guidelines and Advice

PET Evidence from Primary Studies and Systematic Reviews and Recommendations from Clinical Practice Guidelines July 2012 to June 2013

Status: Current
ID: PET 2013-1

May 2014

Guidelines and Advice

Systemic Therapy for Metastatic Urothelial Cancer: An Endorsement of a Portion of the European Association of Urology Guideline on Muscle-Invasive and Metastatic Bladder Cancer

Status: In-Review
ID: GL END 3-24

Aug 2022

Guidelines and Advice

Systemic Therapy in Men with Metastatic Castration-Resistant Prostate Cancer: American Society of Clinical Oncology and Cancer Care Ontario Clinical Practice Guideline

Status: In-Review
ID: 3-15
Version: 2

Sep 2014

Guidelines and Advice

Use of the Epidermal Growth Factor Receptor Inhibitors Gefitinib (Iressa®), Erlotinib (Tarceva®), Afatinib, Dacomitinib or Icotinib in the Treatment of Non–SmallCell Lung Cancer: A Clinical Practice Guideline

Status: In-Review
ID: 7-9
Version: 2

Apr 2014

Guidelines and Advice

Safe Handling of Hazardous Drugs

Status: Current
ID: GL 16-3
Version: 3

Mar 2022

Pages